Skip to main content
Back to General Catalyst

General Catalyst's Biotechnology Portfolio

Browse 27 Biotechnology companies funded by General Catalyst. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
27
Total Funding in Biotechnology
$1.6B

Biotechnology Portfolio Companies (27)

Export
BiotechnologyHealth CareMedical DeviceTherapeutics

Fractyl Health is a biotechnology company that provides curative therapies for metabolic diseases.

Lexington, United States
September 2025
$60.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalTherapeutics

CTRL Therapeutics operates a biotechnology company that researches cell therapy and treatment.

Toronto, Canada
September 2024
$9.1M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

AppsBiotechnologyElectronic Health Record (EHR)GeneticsHealth CarePersonal Health

Color is a healthcare delivery platform that offers cancer prevention, screening programs, and healthcare services for people.

South San Francisco, United States
August 2022
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsLife ScienceMedical Device

Truvian Sciences develops an automated benchtop system to provide lab-accurate blood testing results.

San Diego, United States
July 2024
$74.0M
Series D

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BioinformaticsBiopharmaBiotechnologyMachine Learning

LatchBio is a biotech research company that provides code-free platform for the biocomputing revolution.

San Francisco, United States
June 2022
$28.0M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceMedicalPharmaceuticalPrecision Medicine

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Cambridge, United States
June 2026
$75.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyLife Science

TenSixty BioSciences' goal is to identify novel small molecule therapeutics made possible by combining high throughput experiments.

Cambridge, United States
May 2023
Non-equity Assistance

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareOncologyTherapeutics

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

Boston, United States
May 2026
$25.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

ParcelBio develops biotechnology focused on RNA medicine delivery systems and therapeutic development platforms.

San Francisco, United States
May 2026
$13.2M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyComputer VisionMachine Learning

Optimizing cell therapy with spatial biology

New York, United States
May 2026
$20.0M
Series A

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareHealth Diagnostics

Karius delivers genomic insights into infectious diseases, helping clinicians make critical, life-saving treatment decisions.

Redwood City, United States
May 2024
$100.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceOncologyPharmaceutical

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

Pennsylvania Furnace, United States
May 2026
$250.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Enable medicine is a biotechnology company that develops biological cartography tools to generate cellular maps that help in drug discovery.

Menlo Park, United States
April 2022
$60.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalService IndustryTherapeutics

Rakuten Medical is a biotechnology company developing investigational cancer therapies based on its proprietary Alluminox platform.

San Diego, United States
April 2026
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyGeneticsTherapeutics

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

South San Francisco, United States
April 2026
$150.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical Device

Ossium Health builds a bone marrow bank to treat blood cancers.

San Francisco, United States
April 2026
$15K
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.

Hayward, United States
February 2025
$350.7M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalTherapeutics

Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.

Boston, United States
September 2025
$59.1M
Series D

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyTherapeutics

Tahoe Therapeutics is a biotechnology company that develops AI models of human cells to enhance drug discovery.

South San Francisco, United States
August 2025
$30.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth Diagnostics

Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.

South San Francisco, United States
August 2025
$23.7M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyPharmaceutical

Manas AI is a disruptive drug development AI firm that offers drugs for cancer and rare diseases.

San Francisco, United States
January 2025
$24.6M
Seed

Founder Contacts

30,000+ verified contacts

Alternative MedicineBiotechnologyTherapeutics

Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.

Boston, United States
August 2024
$112.3M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareWomen's

Evvy develops at-home vaginal microbiome tests using metagenomic sequencing to understand symptoms and risks for critical health challenges.

New York, United States
September 2023
$14.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.

Gaithersburg, United States
August 2023
$75.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyE-CommerceInternetMarketplaceRetail

ZAGENO is an enterprise marketplace solution that connects e-commerce to life science.

Cambridge, United States
May 2023
$33.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife Science

CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.

London, United Kingdom
April 2023
$20.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareLife Science

Athelas develops technology to monitor chronically ill patients in their homes.

Mountain View, United States
January 2022
Series C

Founder Contacts

30,000+ verified contacts

Explore General Catalyst's Full Portfolio

View all companies funded by General Catalyst across every industry and funding stage.

View Full General Catalyst Portfolio